dihexa from science bio (also known as PNB-0408) is an experimental small molecule derived angiotensin IV. It was engineered to cross the blood–brain barrier and has shown synaptogenic effects in preclinical models. The often-quoted GLP-1 Condition:NEW BPC-157 10mg | Research
Baker’s notes & crumb story
Description
dihexa from science bio (also known as PNB-0408) is an experimental small molecule derived angiotensin IV. It was engineered to cross the blood–brain barrier and has shown synaptogenic effects in preclinical models. The often-quoted GLP-1 Condition:NEW BPC-157 10mg | Research
BPC-157 10mg | Research Grade Lyophilised Vial | AbsoluteBioLab
3) As mentioned earlier, the DoE authors cited Velasco Herrera et al
GLP-1
Condition:NEW
The addition of glucagon receptor agonism introduces theoretical concerns about hepatic glucose output, though no clinically significant hyperglycemia was observed